Avivagen Valuation
| VIV Stock | CAD 0.01 0.00 0.00% |
Avivagen seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of Avivagen from analyzing the firm fundamentals such as Shares Owned By Insiders of 1.11 %, return on asset of -1.93, and Current Valuation of 7.61 M as well as examining its technical indicators and probability of bankruptcy. In general, most investors favor buying undervalued instruments and disposing overvalued instruments since, at some point, asset prices and their ongoing real values will blend. Key fundamental drivers impacting Avivagen's valuation include:
Enterprise Value 7.6 M | Enterprise Value Ebitda (2.80) | Price Sales 0.5432 | Enterprise Value Revenue 10.6429 |
Overvalued
Today
Please note that Avivagen's price fluctuation is very steady at this time. Calculation of the real value of Avivagen is based on 3 months time horizon. Increasing Avivagen's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Avivagen is useful when determining the fair value of the Avivagen stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Avivagen. Since Avivagen is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Avivagen Stock. However, Avivagen's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.01 | Real 0.0084 | Hype 0.01 |
The real value of Avivagen Stock, also known as its intrinsic value, is the underlying worth of Avivagen Company, which is reflected in its stock price. It is based on Avivagen's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Avivagen's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Avivagen's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Avivagen helps investors to forecast how Avivagen stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Avivagen more accurately as focusing exclusively on Avivagen's fundamentals will not take into account other important factors: Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Avivagen's intrinsic value based on its ongoing forecasts of Avivagen's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Avivagen's closest peers. When choosing an evaluation method for Avivagen, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.
Avivagen Investments |
|
Avivagen Valuation Trend
Knowing Avivagen's actual value is paramount for traders to make sound investment determinations. Avivagen's real value is not only important for the investor to make better decisions but also for a more accurate overall view of Avivagen's financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Avivagen's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.
Avivagen Market Cap
Avivagen is rated fifth in market capitalization category among related companies. Market capitalization of Health Care industry is at this time estimated at about 37.42 Million. Avivagen claims roughly 388,474 in market capitalization contributing just under 2% to equities under Health Care industry.Avivagen Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Avivagen's current stock value. Our valuation model uses many indicators to compare Avivagen value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Avivagen competition to find correlations between indicators driving Avivagen's intrinsic value. More Info.Avivagen is rated fourth in price to earning category among related companies. It is rated fifth in price to sales category among related companies . At this time, Avivagen's Price To Sales Ratio is fairly stable compared to the past year.Comparative valuation analysis is a catch-all model that can be used if you cannot value Avivagen by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Avivagen's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Avivagen's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Avivagen's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Avivagen and how it compares across the competition.
About Avivagen Valuation
The stock valuation mechanism determines the current worth of Avivagen on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Avivagen. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Avivagen based exclusively on its fundamental and basic technical indicators. By analyzing Avivagen's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Avivagen's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Avivagen. We calculate exposure to Avivagen's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Avivagen's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 460.3 K | 400 K | |
| Pretax Profit Margin | (5.81) | (6.10) | |
| Operating Profit Margin | (0.89) | (0.94) | |
| Net Loss | (5.81) | (6.10) | |
| Gross Profit Margin | 0.49 | 0.77 |
8 Steps to conduct Avivagen's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Avivagen's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Avivagen's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Avivagen's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Avivagen's revenue streams: Identify Avivagen's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Avivagen's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Avivagen's growth potential: Evaluate Avivagen's management, business model, and growth potential.
- Determine Avivagen's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Avivagen's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Avivagen. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Complementary Tools for Avivagen Stock analysis
When running Avivagen's price analysis, check to measure Avivagen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avivagen is operating at the current time. Most of Avivagen's value examination focuses on studying past and present price action to predict the probability of Avivagen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avivagen's price. Additionally, you may evaluate how the addition of Avivagen to your portfolios can decrease your overall portfolio volatility.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |